Professor emeritus Arne Ljungqvist from Karolinska Institutet, Stockholm, who has served in various high positions in the IOC, International Association of Athletics Federations (IAAF), Swedish Sports Confederation, to mention some of them, has dedicated a great deal of his life to service in sports and sports medicine. Arne Ljungqvist has especially dedicated his career to the fight against doping and to the protection of the health of the athletes.
It is a great privilege for me to write this editorial as I have known and worked with Arne since the beginning of the 1970s. During the 1980s, I was a member of the Swedish Council of Sports Research under Arne's leadership and later his successor as President. Above all, I have had the privilege to work in the IOC Medical Commission since 1989, and from 2003-2012 under the Chairmanship of Arne. During these years we have worked closely together, and it has been a great journey to learn from Arne how to manage the many difficult and intriguing problems that follows the Olympic Games. Now, Arne is stepping down from the Chairmanship and leaving the IOC Medical Commission this year after years of distinguished service.
It all started over 60 years ago when Arne became a Swedish senior champion in high jump in 1951, jumping as high as 201 cm. Arne was multi-talented and won also the Swedish junior championships in pole vault and javelin. He was one of the favourites for the Gold medal in the high jump competition in the Olympic Games in Helsinki 1952, but unfortunately could not compete because of an injury that he sustained during a medical student carnival in the autumn of 1951 when a group of us were jumping for the general public in the streets with numerous hard landings on asphalt. Arne had to end his jumping career as his injury could not be cured, and it was not until the 1960s that the diagnosis of patellar tendinopathy could be made.
Arne, however, continued his medical studies and soon became very successful. Arne was appointed professor at the Karolinska Institutet in 1972 because of his excellent medical research in the fields of renal and cardiovascular diseases and, later, oncology. He held several high professional positions such as Vice Dean of Medical Faculty, Karolinska Institutet, 1972 -1977 Pro-Rector, Karolinska Institutet, 1977 -1983 This means that Arne is sitting in important international positions in the fight against doping. Arne has really shown that he is equal to the task and has been the leading spokesperson in sport against doping. He is very qualified to hold this position. He is not only the ultimate diplomat but he is also very knowledgeable and skillful in his way of summarising even complex issues and problems. I discovered Arne's great ability in this aspect when I was sitting in the Swedish Council of Sports Research with Arne as a chairperson. Arne seldom gave any personal view on a specific problem or seldom took a direct stand, but when it came to summarise the discussions he would always tell them well, so he would make a brilliant summary and then the decision was easy to make. He has respect not only in the sporting world, but also in the media world.
Arne has been the front-line fighter against doping and his name is today one of the world's most respected within international sports. Arne's contributions in the fight against doping are second to none. He has been an athlete himself, which makes him understand the special language that is present in the athletic situation and also in the locker rooms. He can talk to an athlete in his/her own language and this is an important factor in order to gain the confidence of an athlete. Arne has furthermore had access to the athletic arenas, to the labs and to the boardrooms where the fight against doping has been going on. His position in the Boards of IAAF and the IOC has been unquestioned based on his knowledge, his intelligence and his diplomatic skills. Doping seems to be steadily on the decline, and there is no doubt that Arne has played a key role in this successful work. Arne's legacy in the fight against doping is lasting.
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